SIS3 HCl

Catalog No.S7959 Batch:S795901

Print

Technical Data

Formula

C28H27N3O3.HCl
Molecular Weight 489.99 CAS No. 521984-48-5
Solubility (25°C)* In vitro DMSO 97 mg/mL (197.96 mM)
Ethanol 24 mg/mL (48.98 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description SIS3, a novel specific inhibitor of Smad3, inhibits TGF-β and activin signaling by suppressing Smad3 phosphorylation without affecting the MAPK/p38, ERK, or PI3-kinase signaling pathways.
Targets
Smad3 [1]
In vitro Addition of SIS3 attenuates the effects of TGF-β1 by reducing the transcriptional activity. SIS3 also inhibits the myofibroblast differentiation of fibroblasts by TGF-β1. SIS3 completely diminishes the constitutive phosphorylation of Smad3 as well as the up-regulated type I collagen expression in scleroderma fibroblasts, thus abolishes the ECM overexpression in the TGF-β1-treated normal dermal fibroblasts and scleroderma fibroblasts in vitro[1].
In vivo SIS3 inhibits Smad3 activation in streptozotocin(STZ)-induced diabetic nephropathy in Tie2-Cre;Loxp-EGFP mice. It also reduces AGE-induced EndoMT and decreases EndoMT in STZ-induced diabetic nephropathy in Tie2-Cre;Loxp-EGFP mice. SIS3 significantly reduces collagen IV and fibronectin expression in the glomeruli and tubulointerstitium of STZ-injected Tie2-Cre;Loxp-EGFP mice, suggesting that SIS3 retards the early development of STZ-induced diabetic glomerulosclerosis and tubulointerstitial fibrosis. However, SIS3 administration does not reduce proteinuria[2].

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    Normal human dermal fibroblasts, Scleroderma fibroblasts

  • Concentrations

    0.3, 1, 3 μM

  • Incubation Time

    72 h

  • Method

    Normal human dermal fibroblasts are plated at a density of 105 cells/well in six-well culture plates and grown until subconfluence in MEM containing 10% FCS. Cells are quiesced by 24-h incubation in serum-free MEM, followed by incubation in serum-free medium in the presence or absence of SIS3 before the collection of cells for 72 h. Then, the cells are detached from the wells by trypsin treatment and counted using a Coulter counter.
Animal Study:

[2]
  • Animal Models

    Male C57BL/6J mice

  • Dosages

    1, 2.5, or 5 μg/g

  • Administration

    i.p.

Customer Product Validation

, , Circ Res, 2017, 121(6):617-627

Data from [Data independently produced by , , Cell Physiol Biochem, 2017, 44(6):2201-2211]

Data from [Data independently produced by , , Lab Invest, 2018, doi: 10.1038/s41374-018-0091-y]

Data from [Data independently produced by , , Biochem Biophys Res Commun, 2018, 503(2):757-762]

Selleck's SIS3 HCl has been cited by 79 publications

Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling [ Int J Biol Sci, 2024, 20(1):200-217] PubMed: 38164169
Sleeve gastrectomy links the attenuation of diabetic kidney disease to the inhibition of renal tubular ferroptosis through down-regulating TGF-β1/Smad3 signaling pathway [ J Endocrinol Invest, 2024, 10.1007/s40618-023-02267-1] PubMed: 38512446
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma [ Nat Commun, 2023, 14(1):1794] PubMed: 37002229
Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma [ Nature Communications-, 2023, 1794-2023)] PubMed: None
A critical role for heme synthesis and succinate in the regulation of pluripotent states transitions [ Elife, 2023, 12e78546] PubMed: 37428012
A critical role for heme synthesis and succinate in the regulation of pluripotent states transitions [ Elife, 2023, 12e78546] PubMed: 37428012
Suppression of TGFβR-Smad3 pathway alleviates the syrinx induced by syringomyelia [ Cell Biosci, 2023, 13(1):98] PubMed: 37248485
Smad3 Mediates Diabetic Dyslipidemia and Fatty Liver in db/db Mice by Targeting PPARδ [ Int J Mol Sci, 2023, 24(14)11396] PubMed: 37511155
Investigating the Role of TGF-β Signaling Pathways in Human Corneal Endothelial Cell Primary Culture [ Cells, 2023, 12(12)1624] PubMed: 37371094
Resveratrol inhibits TGF-β1-induced fibrotic effects in human pterygium fibroblasts [ Environ Health Prev Med, 2023, 28:59] PubMed: 37866886

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.